Overview

Pharmacokinetics of Two Formulation of Pregabalin

Status:
Completed

Trial end date:
2018-12-03

Target enrollment:

Participant gender:

Summary

A Randomized, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of Two Formulations of Pregabalin after Oral Administration in Healthy Volunteers under Fasting Conditions

Phase:

Phase 4

Details

Lead Sponsor:

Yung Shin Pharm. Ind. Co., Ltd.

Collaborator:

Taichung Veterans General Hospital

Treatments:

Pregabalin